Lantheus says CMS grants transitional pass-through reimbursement for PYLARIFY TruVu
CMS granted Transitional Pass-Through payment status for PYLARIFY TruVu effective Oct. 1, 2026, and assigned a permanent HCPCS code.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lantheus says CMS grants pass-through status for PYLARIFY TruVu
CMS granted transitional pass-through status for PYLARIFY TruVu (piflufolastat F 18).